Latest Content

Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.

Here's the latest on the cyclosporiasis and jalapeño-linked Salmonella case numbers, plus an update on the resolved avocado inspection halt. Also included is information on a bacterial infection linked to shellfish, and a look at efforts affecting cyclosporiasis research.

Adding bismuth to amoxicillin-vonoprazan increased efficacy of the combination for H pylori, and exceeded that of clarithromycin-based triple therapy without contributing to clarithromycin resistance.

In the third episode of the series with Perry N. Halkitis, PhD, MS, MPH, he discusses how human behavior as well as other factors play a significant role in repeating outbreaks.

Editor-in-Chief Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, discusses the proposed OMB rule restricting federal grants for international research collaboration, and how it threatens infectious disease medicine's inherently borderless surveillance networks, publication access, and knowledge-sharing systems.

The Vaccine Integrity Project, in collaboration with the American Medical Association, conducted a vaccine and immunization effectiveness and safety review for RSV, Influenza, and COVID-19 for the 2026-2027 season. JAMA published the review, and here is an overview of the data going into this year's seasonal respiratory virus season.

Kofinas Mediterranean olive oil was recalled over an unapproved garlic flavoring ingredient, and a new update on Lundberg Family Farms' jasmine rice recall tied to foreign material contamination.

The expanding gram-negative antibiotic pipeline offers important new treatment options; however, FDA approval alone does not define a drug’s place in therapy. Clinicians must weigh the clinical problems that each agent solves, the strength of the evidence behind it, and what remains unknown before incorporating these therapies into routine practice.

The antiviral did not produce greater symptom improvement than placebo in patients with the condition in the RECOVER-VITAL trial.

Vibrio species are bacteria that live in saltwater environments. When ingested orally or through contact with open wounds, some species can cause severe life-threatening infections, particularly in those with high-risk conditions, such as liver disease. Here is a review of Vibrio vulnificus and the recommended antibiotic treatment.

Here is a comprehensive list of vaccines approved this year as well as background information on the clinical data for each of them.

A shortened, response-tailored antibiotic treatment of infective endocarditis was associated with longer survival, but higher incidence of relapse.

Although azithromycin or another antibiotic is given to an estimated one of four preschool-age children in emergency departments for wheezing episodes, it failed to demonstrate benefit in a new multi-center trial.